Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Background/Aims: Hypoxia-inducible factor-1α (HIF-1α) is a central transcriptional factor involved in the cellular responses related to various aspects of cancer biology, including proliferation, survival, and angiogenesis, and the metabolism of the extracellular matrix in hypoxia. This study evaluated whether adenovirus-mediated small hairpin RNA (shRNA) against HIF-1α (shHIF-1α) inhibits cell proliferation and angiogenesis in hepatocellular carcinoma (HCC) cell lines. Methods: Knockdown of HIF-1α expression was constructed by adenovirus-mediated RNA interference tools, and HCC cell lines infected with shHIF-1α coding virus were cultured under a hypoxia condition (1% O2) for 24 hours. Following infection, the expression levels of HIF-1α, angiogenesis factors, and matrix metalloproteinase (MMP) were examined using Western blotting. Cell proliferation and angiogenesis were measured by a cell proliferation assay (MTT assay) and an angiogenesis-related assay (invasion and tube-formation assay), respectively. Results: Adenovirus mediated inhibition of HIF-1α induced suppression of tumor growth in HCC cell lines. It also down-regulated the expression of angiogenesis factor and MMP proteins. Angiogenesis as well as mobility of vascular cells to tumor was suppressed by adenovirus-mediated shHIF-1α-infected groups in human umbilical vein endothelial cells (HUVECs). Conclusions: These data suggest that adenovirus-mediated inhibition of HIF-1αinhibits the invasion, tube formation, and cell growth in HUVECs and HCC cells.
Abstract
Background/Aims: Hypoxia-inducible factor-1α (HIF-1α) is a central transcriptional factor involved in the cellular responses related to various aspects of cancer biology, including proliferation, survival, and angiogenesis, and the metabolism of the extracellular matrix in hypoxia. This study evaluated whether adenovirus-mediated small hairpin RNA (shRNA) against HIF-1α (shHIF-1α) inhibits cell proliferation and angiogenesis in hepatocellular carcinoma (HCC) cell lines. Methods: Knockdown of HIF-1α expression was constructed by adenovirus-mediated RNA interference tools, and HCC cell lines infected with shHIF-1α coding virus were cultured under a hypoxia condition (1% O2) for 24 hours. Following infection, the expression levels of HIF-1α, angiogenesis factors, and matrix metalloproteinase (MMP) were examined using Western blotting. Cell proliferation and angiogenesis were measured by a cell proliferation assay (MTT assay) and an angiogenesis-related assay (invasion and tube-formation assay), respectively. Results: Adenovirus mediated inhibition of HIF-1α induced suppression of tumor growth in HCC cell lines. It also down-regulated the expression of angiogenesis factor and MMP proteins. Angiogenesis as well as mobility of vascular cells to tumor was suppressed by adenovirus-mediated shHIF-1α-infected groups in human umbilical vein endothelial cells (HUVECs). Conclusions: These data suggest that adenovirus-mediated inhibition of HIF-1αinhibits the invasion, tube formation, and cell growth in HUVECs and HCC cells.
참고문헌 (30)
- Semela D, "Angiogenesis and hepatocellular carcinoma", J Hepatol, 41, pp.864~880 (2004)
- Yoshiji H, "Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells", Hepatology, 28, pp.1489~1496 (1998)
- Yamaguchi R, "Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues", Oncol Rep, 7, pp.725~729 (2000)
- Fox SB, "Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs", Lancet Oncol, 2, pp.278~289 (2001)
- Longo R, "Anti-angiogenic therapy: rationale, challenges and clinical studies", Angiogenesis, 5, pp.237~256 (2002)
- Pugh CW, "Regulation of angiogenesis by hypoxia: role of the HIF system", Nat Med, 9, pp.677~684 (2003)
- Carmeliet P, "Angiogenesis in cancer and other diseases", Nature, 407, pp.249~257 (2000)
- Nava S, "Non-invasive ventilation in acute respiratory failure", Lancet, 374, pp.250~259 (2009)
- Chen J, "Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation", Am J Pathol, 175, pp.400~411 (2009)
- Guarente L, "Cell biology Hypoxic hookup", Science, 324, pp.1281~1282 (2009)
- Harris AL, "Hypoxia-a key regulatory factor in tumour growth", Nat Rev Cancer, 2, pp.38~47 (2002)
- Shimamura T, "Detection of vascular endothelial growth factor and its receptor expression in human hepatocellular carcinoma biopsy specimens", J Gastroenterol Hepatol, 15, pp.640~646 (2000)
- El-Assal ON, "Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver", Hepatology, 27, pp.1554~1562 (1998)
- Semenza GL, "Targeting HIF-1 for cancer therapy", Nat Rev Cancer, 3, pp.721~732 (2003)
- Mizukami Y, "Iliopoulos O, Chung DC. Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer", Cancer Res, 64, pp.1765~1772 (2004)
- Kim J, "Evaluation of E1B gene attenuated replicating adenoviruses for cancer gene therapy", Cancer Gene Ther, 9, pp.725~736 (2002)
- Yoo JY, "Short hairpin RNA-expressing oncolytic adenovirus mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition", Gene Ther, 15, pp.635~651 (2008)
- Bergers G, "Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis", Nat Cell Biol, 2, pp.737~744 (2000)
- Kim JH, "Analysis of matrix metalloproteinase mRNAs expressed in hepatocellular carcinoma cell lines", Mol Cells, 12, pp.32~40 (2001)
- Monvoisin A, "Desmoulière A, Rosenbaum J. Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells", Int J Cancer, 97, pp.157~162 (2002)
- Yamamoto H, "Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma", Gastroenterology, 112, pp.1290~1296 (1997)
- Mizukami Y, "Induction of interleukin-8 preserves the angiogenic response in HIF-1alphadeficient colon cancer cells", Nat Med, 11, pp.992~997 (2005)
- Masuya D, "The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients", Cancer, 92, pp.2628~2638 (2001)
- Mise M, "Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor", Hepatology, 23, pp.455~464 (1996)
- Haasnoot J, "RNA interference against viruses: strike and counterstrike", Nat Biotechnol, 25, pp.1435~1443 (2007)
- Grimm D, "Fatality in mice due to oversaturation of cellular microRNA", short hairpin RNA pathways, 2006, pp.441, 537~541
- Martin SE, "Applications of RNA interference in mammalian systems", Annu Rev Genomics Hum Genet, 8, pp.81~108 (2007)
- Czauderna F, "Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells", Nucleic Acids Res, 31, pp.2705~2716 (2003)
- Barton GM, "Retroviral delivery of small interfering RNA into primary cells", Proc Natl Acad Sci USA, 99, pp.14943~14945 (2002)
- Arts GJ, "Adenoviral vectors expressing siRNAs for discovery and validation of gene function", Genome Res, 13, pp.2325~2332 (2003)